Robert Lim
Impact in
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
-
- Neonatal Respiratory Health Research 1
- Inhalation and Respiratory Drug Delivery 1
- Oncology 2
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Eric Van Cutsem (2 shared papers)Michael Schlichting (1 shared paper)Jae Kyung Roh (1 shared paper)C.-H. Köhne (1 shared paper)Gyorgy Bodoky (1 shared paper)Gunnar Folprecht (1 shared paper)Paul Ruff (1 shared paper)Johannes Nippgen (1 shared paper)
- Journals
- New England Journal of Medicine (2 papers)Annals of the American Thoracic Society (1 paper)Journal of Clinical Oncology (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Therapeutic Innovation & Regulatory Science (1 paper)
- Partner nations
- United StatesSingaporeSouth Korea
In The Last Decade
Robert Lim
8 papers receiving 3.5k citations
Robert Lim's Hit Papers
Peers
Comparison fields: 5 of 88
- Oncology 2.5k
- Cancer Research 207
- Pulmonary and Respiratory Medicine 316
- Pathology and Forensic Medicine 144
- Hepatology 67
Countries citing papers authored by Robert Lim
This map shows the geographic impact of Robert Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Lim more than expected).
Fields of papers citing papers by Robert Lim
This network shows the impact of papers produced by Robert Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Lim. The network helps show where Robert Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer Hit paper breakdown → | 2009 | 3202 |
| 2 | 2006 | 235 | |
| 3 | 2017 | 124 | |
| 4 | 2008 | 23 | |
| 5 | 2018 | 18 | |
| 6 | 2023 | 6 | |
| 7 | 2021 | 5 | |
| 8 | 2020 | 2 |
About Robert Lim
Robert Lim is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Toxicology, Pharmacology and Statistics and Probability, having authored 8 papers that have together received 3.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (2 papers), Neonatal Respiratory Health Research (1 paper), Genomics and Rare Diseases (1 paper), Pharmacogenetics and Drug Metabolism (1 paper), Antifungal resistance and susceptibility (1 paper), Inhalation and Respiratory Drug Delivery (1 paper), Statistical Methods in Clinical Trials (1 paper) and Pharmacovigilance and Adverse Drug Reactions (1 paper). The work is most often cited by research in Oncology (2.5k citations), Cancer Research (207 citations), Pulmonary and Respiratory Medicine (316 citations), Pathology and Forensic Medicine (144 citations) and Hepatology (67 citations). Robert Lim has collaborated with scholars based in United States, Singapore and South Korea. Frequent co-authors include Eric Van Cutsem, Michael Schlichting, Jae Kyung Roh, C.-H. Köhne, Gyorgy Bodoky, Gunnar Folprecht, Paul Ruff, Johannes Nippgen, Philippe R Rougier and Jerzy Załuski. Their work appears in journals such as New England Journal of Medicine, Annals of the American Thoracic Society, Journal of Clinical Oncology, Clinical Pharmacology & Therapeutics and Therapeutic Innovation & Regulatory Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.